EQ

Equasens SAPAR Equasens Stock Report

Last reporting period 31 Dec, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

1.256

Small

Exchange

XPAR - Euronext Paris

EQS.PA Stock Analysis

EQ

Uncovered

Equasens SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

100/100

High score

Market cap $B

1.256

Dividend yield

4.36 %

Shares outstanding

15.007 B

Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the development and integration of management software packages for drugstores. The company offers all IT (Information Technology) and High-Tech fields related to Health and in specialized fields which are associated to it such as IT for pharmacies, solutions for e-Health, solutions for pharmaceutical industry, solutions for patients etc. The firm operates in four divisions that includes Europe Pharmacy Solutions Division including France Pharmacy Section and Belgium and Luxembourg Pharmacy Section, Solutions for sanitary and medico-social entities Division, e-Health Solutions Division including e-Laboratories section, e-Patients section and e-Connect section and Fintech Division.

View Section: Eyestock Rating